Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05160532
PHASE2

Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

The purpose of this research is to learn more about treating Symptomatic Knee Osteoarthritis (OA) with an ultrasound-guided hypertonic dextrose injection. Researchers would like to determine best practice for injection frequency and effectiveness of the dextrose injection for symptomatic knee OA.

Key Details

Gender

All

Age Range

40 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2022-04-10

Completion Date

2025-05-31

Last Updated

2026-06-30

Healthy Volunteers

No

Interventions

DRUG

Placebo

5ml of normal saline (NS)

DRUG

Dextrose prolotherapy (DPT)

25% dextrose, mixing 2.5ml of sterile water and 2.5ml of 50% dextrose.

Locations (1)

Mayo Clinic in Arizona

Scottsdale, Arizona, United States